Biomerica Inc
BMRA- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000073290
In the last 90 days, Biomerica Inc insiders filed 5 open-market purchases and 0 sales; 20 institutions reported holding it in 13F filings for Q2 2026, worth $220.0K in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Biomerica Inc as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 13
- −4 vs. Q3 2025
- Shares held
- 89.5K
- +657 (+0.7%) vs. Q3 2025
- Total value
- $225.4K
- −$25.9K (−10.3%) vs. Q3 2025
- New holders
- 0
- 5 more added
- Sold out
- 4
- 1 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BMRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 20 | $220.0K |
| Q1 2026 | 11 | $236.1K |
| Q4 2025 | 13 | $225.4K |
| Q3 2025 | 17 | $251.3K |
| Q2 2025 | 12 | $219.6K |
| Q1 2025 | 24 | $542.9K |
| Q4 2024 | 21 | $420.8K |
| Q3 2024 | 25 | $532.7K |
| Q2 2024 | 35 | $982.4K |
| Q1 2024 | 36 | $3.10M |
| Q4 2023 | 33 | $4.68M |
| Q3 2023 | 35 | $3.43M |
| Q2 2023 | 36 | $6.00M |
| Q1 2023 | 34 | $8.83M |
| Q4 2022 | 30 | $11.6M |
| Q3 2022 | 31 | $11.6M |
| Q2 2022 | 26 | $7.01M |
| Q1 2022 | 28 | $11.3M |
| Q4 2021 | 24 | $9.29M |
| Q3 2021 | 22 | $11.0M |
| Q2 2021 | 27 | $10.2M |
| Q1 2021 | 32 | $20.4M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Biomerica Inc; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Danske Bank A/S | 1 | $3 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 2 | $5 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 49 | $124 | 0.00% | +4+8.9% | Added |
| Harbour Investments, Inc. | 125 | $315 | 0.00% | 00.0% | Unchanged |
| CIBC Private Wealth Group, LLC | 662 | $1.67K | 0.00% | +150+29.3% | Added |
| Hollencrest Capital Management | 1,450 | $3.65K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 2,433 | $6.13K | 0.00% | +1,633+204.1% | Added |
| GWM Advisors LLC | 3,603 | $9.08K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 5,812 | $14.6K | 0.00% | +5,697+4,953.9% | Added |
| DRW Securities, LLC | 16,925 | $42.7K | 0.00% | +6,533+62.9% | Added |
| Geode Capital Management, LLC | 18,627 | $46.9K | 0.00% | −2,356−11.2% | Reduced |
| BlackRock, Inc. | 18,636 | $47.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 21,127 | $53.2K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −10,472−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −194−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −169−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −169−100.0% | Sold out |